Jinyu Bio-Technology Co

Jinyu Bio-Technology Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Jinyu Bio-Technology Co (600201.SS) as of Oct 27, 2026 is 194.47 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 183.41 % — a change of 6.03% (higher).

FCF Conversion

194.47 %

YoY

6.03%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Jinyu Bio-Technology Co is 2025 194.47 % . FCF Conversion Rate (FCF/EBITDA) of Jinyu Bio-Technology Co was 2024 183.41 % . It decreases by 6.03% higher compared to the previous year.

The Jinyu Bio-Technology Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-16.30 CNY
Jan 1, 2019
44.28 CNY
Jan 1, 2020
116.03 CNY
Jan 1, 2021
41.96 CNY
Jan 1, 2022
73.36 CNY
Jan 1, 2023
49.95 CNY
Jan 1, 2024
183.41 CNY
Jan 1, 2025
194.47 CNY
The Jinyu Bio-Technology Co FCF Conversion history
YEARFCF ConversionYoY
194.47 %+6.03%
183.41 %+267.19%
49.95 %-31.91%
73.36 %+74.84%
41.96 %-63.84%
116.03 %+162.02%
44.28 %-371.61%
-16.30 %-128.98%
56.26 %-41.69%
96.48 %+99.48%
48.37 %-48.34%
93.63 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jinyu Bio-Technology Co Stock analysis

What does Jinyu Bio-Technology Co do? Jinyu Bio-Technology Co., Ltd. generates revenue by researching, developing, producing, and selling veterinary biological products, with a primary focus on veterinary vaccines. The company operates from its headquarters in Hohhot, Neimenggu, where it employs 1,618 full-time staff members to support these core activities. In addition to its main veterinary operations, the firm diversifies its income streams by engaging in textile processing, providing energy products, and offering property leasing and management activities. These supplementary services allow the company to serve various market segments beyond the veterinary sector. The business model relies on the direct sale of its veterinary vaccines and biological products to customers in the animal health industry. By integrating manufacturing with research and development, Jinyu Bio-Technology Co., Ltd. maintains control over its product quality and supply chain while expanding into related industrial and service areas. Jinyu Bio-Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jinyu Bio-Technology Co stock

FCF Conversion Rate (FCF/EBITDA) of Jinyu Bio-Technology Co is 194.47 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Jinyu Bio-Technology Co changed from 183.41 % to 194.47 %, representing a 6.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Jinyu Bio-Technology Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Jinyu Bio-Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Jinyu Bio-Technology Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Jinyu Bio-Technology Co